GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » NeueHealth Inc (NYSE:NEUE) » Definitions » Capex-to-Operating-Cash-Flow

NeueHealth (NeueHealth) Capex-to-Operating-Cash-Flow : 0.00 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is NeueHealth Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

NeueHealth's Capital Expenditure for the three months ended in Mar. 2024 was $-0.06 Mil. Its Cash Flow from Operations for the three months ended in Mar. 2024 was $-48.72 Mil.

GuruFocus do not calculate Capex-to-Operating-Cash-Flow if the Cash Flow from Operations is negative.


NeueHealth Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for NeueHealth's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeueHealth Capex-to-Operating-Cash-Flow Chart

NeueHealth Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial - - 0.37 0.12 -

NeueHealth Quarterly Data
Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of NeueHealth's Capex-to-Operating-Cash-Flow

For the Healthcare Plans subindustry, NeueHealth's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NeueHealth's Capex-to-Operating-Cash-Flow Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, NeueHealth's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where NeueHealth's Capex-to-Operating-Cash-Flow falls into.



NeueHealth Capex-to-Operating-Cash-Flow Calculation

NeueHealth's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-2.897) / -2726.546
=N/A

NeueHealth's Capex-to-Operating-Cash-Flow for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-0.064) / -48.717
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NeueHealth  (NYSE:NEUE) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


NeueHealth Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of NeueHealth's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


NeueHealth (NeueHealth) Business Description

Traded in Other Exchanges
N/A
Address
8000 Norman Center Drive, Suite 900, Minneapolis, MN, USA, 55437
Bright Health Group Inc is a technology-enabled, value-driven healthcare company focused on delivering affordable healthcare to the fast-growing aging and underserved populations in Florida, Texas, and California. It consists of two reportable segments: Bright HealthCare includes delegated senior managed care business that partners with a tight group of aligned providers in California focused on serving aging and underserved populations with unmet clinical needs through a Fully-Aligned Care Model, and Consumer Care includes a value-driven care delivery business that manages risk in partnership with external payors, It aims to significantly reduce the friction and current lack of coordination between payors by delivering on its Fully-Aligned Care Model with multiple payors.
Executives
Mikan George Lawrence Iii director, officer: CEO and President 200 SW 1ST AVE, SUITE 1600, FORT LAUDERDALE FL 33301
Jay Matushak officer: Chief Financial Officer C/O BRIGHT HEALTH GROUP, INC., 8000 NORMAN CENTER DRIVE, SUITE 900, MINNEAPOLIS MN 55437
Jeffrey S Cook officer: CEO, NeueHealth C/O BRIGHT HEALTH GROUP INC, 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437
Jeffrey J Scherman officer: Chief Accounting Officer C/O BRIGHT HEALTH GROUP, INC., 8000 NORMAN CENTER DRIVE, SUITE 1200, MINNEAPOLIS MN 55437
Cathy R Smith officer: CFO & CAO TARGET CORPORATION, 1000 NICOLLET MALL, TPS-3155, MINNEAPOLIS MN 55403
Jeff Michael Craig officer: GC & CORPORATE SECRETARY C/O BRIGHT HEALTH GROUP INC, 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437
Manuel Kadre director 2020 SALZEDO STREET, SUITE 301, CORAL GABLES FL 33134
Jeffrey R Immelt director GENERAL ELECTRIC COMPANY, 41 FARNSWORTH STREET, BOSTON MA 02210
Nea 18 Vge Gp, Llc 10 percent owner C/O NEW ENTERPRISE ASSOCIATES, 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea Partners 18 Vge, L.p. 10 percent owner C/O NEW ENTERPRISE ASSOCIATES, 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea 18 Venture Growth Equity, L.p. 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea 17 Gp, Llc 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Nea Partners 17, L.p. 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
New Enterprise Associates 17, L.p. 10 percent owner 1954 GREENSPRING DRIVE, SUITE 600, TIMONIUM MD 21093
Michael A Carson officer: CEO, Bright HealthCare C/O BRIGHT HEALTH GROUP INC., 8000 NORMAN CENTER DRIVE SUITE 1200, MINNEAPOLIS MN 55437

NeueHealth (NeueHealth) Headlines

From GuruFocus